fda glp-1 compounding warning october 2025 letters Pharmacovigilance Assessment of Compounded GLP-1 Receptor Agonists: Insights From the FDA Adverse Event Reporting System FDA is moving to restrict

The most frequently prescribed options in the medical industry are semaglutide (the active compound found in Wegovy and Ozempic) and tirzepatide (the active compound in Zepbound and Mounjaro)

Lixisenatide: Gastrointestinal: acute pancreatitis, hemorrhagic and necrotizing pancreatitis, ileus, intestinal obstruction, severe constipation including fecal impaction Hepatobiliary: cholecystitis, cholelithiasis requiring cholecystectomy Neurologic: dysgeusia, dysesthesia Pulmonary: pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists under-going elective surgeries or procedures requiring general anesthesia or deep sedation

According to MarkWide Research, Gourmand fragrances have seen a huge surge in popularity, which they say is down to their indulgent scent

And it goes back again, just like I talked about before

3a,b,d,e)

GLP-1 is a natural hormone that helps control appetite and boost weight loss, while Ozempic is an effective medication that mimics GLP-1s effects for lasting results